カタログ製品コード : C-EK11882
Human B4GALT1/GGTB2 ELISA kit
24T | ¥100,200 | (¥4,175/T) (税別) |
48T | ¥114,200 | (¥2,379/T) (税別) |
96T | ¥123,000 | (¥1,281/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-EK11882
Human B4GALT1/GGTB2 ELISA kit
24T | ¥100,200 | (¥4,175/T) (税別) |
48T | ¥114,200 | (¥2,379/T) (税別) |
96T | ¥123,000 | (¥1,281/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
MultiSciences | B4GALT1/GGTB2 | Human | 1.56 - 100 ng/ml | 50 μl | 血清、血漿、細胞培養上清 |
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
96-well polystyrene microplate coated with a monoclonal antibody against B4GALT1 |
Human B4GALT1 Standard, lyophilized |
B4GALT1 Detect Antibody |
Standard Diluent |
Assay Buffer (10×) |
Substrate (TMB) |
Stop Solution |
Washing Buffer (20×) |
Plate Covers |
■キーワード :
Homo sapiens,Human,Beta-1,4-galactosyltransferase 1,Beta-1,4-GalTase 1,Beta4Gal-T1,b4Gal-T1,UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1,UDP-galactose:beta-N-acetylglucosamine beta-1,4
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human B4GALT1. The Human B4GALT1/GGTB2 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Beta-1, 4-galactosyltransferase 1 (B4GALT1), one of seven beta-1, 4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds galactose to oligosaccharides. By sequence similarity, the B4GALTs form four groups: B4GALT1 and B4GALT2, B4GALT3 and B4GALT4, B4GALT5 and B4GALT6, and B4GALT7. B4GALT1 is unique among the seven enzymes because it can be expressed either as membrane associated form or secreted form. The secreted form is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha - lactalbumin to catalyze the synthesis of lactose. The membrane form can reside either in the Golgi apparatus, where it adds galactose to N-acetylglucosamine residues, or on cell surface, where it functions as a recognition molecule during a variety of cell to cell and cell to matrix interactions, by binding to specific oligosaccharide ligands on opposing cells or in the extracellular matrix. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Defects in B4GALT1 are the cause of congenital disorder of glycosylation type 2D.